Sign inJoin waitlistJoin the waitlist

WK

Wm Kelly

Chair & Professor, Department of Medical Oncology · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY

Credentials: · · · ·

History

Department of Medical Oncology · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present
Sidney Kimmel Comprehensive Cancer Center Division · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present
SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
1995–1998
Cornell University Medical College
1993–1995
Albert Einstein Medical Center
1990–1993
Internal Medicine
Jefferson Health Medical Education
1987–1990
St. Joseph's Hospital
1986–1987
Philadelphia College of Osteopathic Medicine
1982–1986

Research

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials…
Journal of Clinical Oncology · 2008 · 1,931 citations
Histone deacetylases and cancer: causes and therapies
Review · Nature reviews. Cancer · 2001 · Last of 6 authors · 1,570 citations
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
Journal of Clinical Oncology · 2005 · First of 16 authors · Corresponding · 769 citations

HS
Howard Scher
61 papers
MM
Michael Morris
35 papers
LG
Leonard Gomella
31 papers
Eric Small
29 papers
SS
Susan Slovin
27 papers · 4 as a fellow
Costas Lallas
21 papers
LS
Lawrence Schwartz
20 papers
Edouard Trabulsi
19 papers
Adam Dicker
14 papers
JL
Jianqing Lin
13 papers
MC
Michael Carducci
13 papers
Daniel Petrylak
12 papers

Grants

Translational Research in Cancer
National Cancer Institute · P30
Project lead · $2.2M · Thomas Jefferson University
1995–2029
Genomic Profiling of Single Circulating Tumor Cells in the Precision Medicine of Metastatic Prostate Cancer
National Cancer Institute · R01
PI · $3.2M · Thomas Jefferson University
2021–2027
Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer
National Cancer Institute · R01
PI · $1.8M · Thomas Jefferson University
2017–2023
Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $676.7K · Yale University
2007–2013

Clinical trials

Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression
Principal investigator · Terminated · Phase 1, Phase 2
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
2015–2023